首页> 美国卫生研究院文献>Neuro-Oncology >DIPG-12. PALLIATIVE TREATMENT FOR DIPG (DIFFUSE INTRINSIC PONTINE GLIOMA) AT KOBE CHILDREN’S HOSPITAL IN JAPAN
【2h】

DIPG-12. PALLIATIVE TREATMENT FOR DIPG (DIFFUSE INTRINSIC PONTINE GLIOMA) AT KOBE CHILDREN’S HOSPITAL IN JAPAN

机译:DIPG-12。日本神户儿童医院DIPG(弥漫性内源性胶体神经胶质瘤)的姑息治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTIONBrain stem glioma is common pediatric brain tumor that accounts for 8~20% of them and diffuse intrinsic pontine glioma (DIPG) is the majority. The consensus treatment is radiotherapy but prognosis is very poor, thus most of the cases indicate tumor death and the average survival period is about a year. In most cases, neurosurgeon would be the first specialist doctor whom the family consult with and give the great influence to them. Therefore, it is necessary for us to lead the treatment and also palliative treatment in brain tumor care team at our institute. This report reflects our experience of palliative treatment for 19 DIPG cases in 265 central nervous system tumor from 2010 to 2017.
机译:引言脑干神经胶质瘤是常见的小儿脑肿瘤,占8〜20%,弥漫性桥脑神经胶质瘤(DIPG)占多数。共识疗法是放射疗法,但预后很差,因此大多数病例表明肿瘤死亡,平均生存期约为一年。在大多数情况下,神经外科医生将是该家庭咨询的第一位专科医生,并对其产生巨大影响。因此,有必要在我所脑肿瘤护理小组中领导治疗以及姑息治疗。本报告反映了我们从2010年至2017年对265例中枢神经系统肿瘤19例DIPG进行姑息治疗的经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号